|
⚲
|
| Linden Advisors LP
✚
| |
|---|---|
| CRD # | 135431 |
| SEC # | 801-65641 |
| CIK # | 0001279396 |
| AUM | $18.8 BB (2024-03-14) |
| Employees | 46 (52% Investors, 0% Brokers) |
| Phone | 646-840-3500 |
| Address | 590 Madison Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($BB) |
|---|
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| HF | PCH Manager Fund SPC - Segregated Portfolio 214 | [2019-10-28] | 101.6 | 678.7 |
| HF | Linden Focused Metric Fund Ltd | [2016-02-26] | 1.0 | 0.0 |
| HF | Linden Capital LP | [2012-03-29] | 697.9 | 17,512.9 |
| AUM Breakdown | Accounts | AUM ($BB) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 5 | 18.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 5 | 18.8 |
| By Discretionary | ||
| Discretionary | 5 | 18.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 5 | 18.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 18.8 | |
| United States Persons | 0.0 | |
| Total | 5 | 18.8 |
| Form D Directors | # Filings | # Firms | 2011 - 2024 | |
|---|---|---|---|---|
| Michelle WilsonClarke | 277 | |||
| John Ackerley | 165 | |||
| Carlos Ferreira | 91 | |||
| James Keyes | 152 | |||
| Vincent Cuticello | 22 | |||
| Roderick Forrest | 34 | |||
| Sean Fang | 11 | |||
| Nicholas Hoskins | 22 | |||
| Linden Advisors LP | 2 | |||
| Saul Ahn | 2 | |||
| View All | ||||
| EDGAR Form | CIK | 2011 - 2024 |
|---|---|---|
| 13F-HR | [0001279396] | |
| 3 | [0001279396] | |
| 4 | [0001279396] | |
| SC 13D | [0001279396] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Linden Advisors LP | Tetralogic Pharmaceuticals Corp | [2016-11-14] |
| Form 3/4/5 Subject | 2011 - 2024 |
|---|---|
| TETRALOGIC PHARMACEUTICALS Corp | |
| Linden Capital L.P. | |
| Linden Advisors LP |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
Axiom Investors LLC
✚
|
CT | 20.2 |
|
Centiva Capital LP
✚
|
NY | 19.0 |
|
Graham Capital Management LP
✚
|
CT | 18.6 |
|
Pershing Square Capital Management LP
✚
|
NY | 18.6 |
|
Onex Credit Partners LLC
✚
|
NJ | 18.3 |
|
Varde Management LP
✚
|
MN | 18.1 |
|
The Rock Creek Group LP
✚
|
DC | 17.7 |
|
Twentyfour Asset Management US LP
✚
|
NY | 17.6 |
|
Lee Overlay Partners Ltd
✚
|
17.4 | |
|
Allianz Investment Management LLC
✚
|
MN | 17.3 |